Assignee profile:

Immunwork Inc.

City:

Taipei

Country:

Taiwan

Published Applications:

16

Last publication date:

2022-03-03

Patent Grants:

14

Last grant date:

2024-03-12

Top Inventors for applications by Immunwork Inc.

These are the the leading inventors for applications assigned to Immunwork Inc.:

Recent patent applications by Immunwork Inc.

Immunwork Inc. based in Taipei, TW has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-03-03 ✅ Patent 11,926,678 granted on 2024-03-12
US20220064215A1
Chemistry; metallurgy

Composite polypeptide having a metal binding motif and molecular construct comprising the same

#2 | 2020-10-01 ✅ Patent 11,203,614 granted on 2021-12-21
US20200308223A1
Chemistry; metallurgy

Composite polypeptide having a metal binding motif and molecular construct comprising the same

#3 | 2020-07-16 ✅ Patent 10,993,986 granted on 2021-05-04
US20200222498A1
Human necessities

Pharmaceutical constructs with enhanced binding affinity with albumin

#4 | 2020-05-21 ✅ Patent 11,220,680 granted on 2022-01-11
US20200157519A1
Chemistry; metallurgy

Polypeptide for treating pathological blood clots

#5 | 2018-09-20 ✅ Patent 10,894,091 granted on 2021-01-19
US20180264133A1
Human necessities

Linker units and molecular constructs comprising the same

#6 | 2018-09-20 ✅ Patent 11,235,064 granted on 2022-02-01
US20180264129A1
Human necessities

Core constructs and their uses in configuring pharmaceutical molecules

#7 | 2018-04-26
US20180110872A1
Human necessities

MULTI-ARM LINKERS FOR CONSTRUCTING PHARMACEUTICAL MOLECULES

#8 | 2017-06-01
US20170152323A1
Chemistry; metallurgy

Anti-inflammatory molecules with tissue-targeting functions

#9 | 2017-03-02 ✅ Patent 10,293,018 granted on 2019-05-21
US20170056521A1
Human necessities

Fusion protein for treating rejection reaction in transplantation

#10 | 2017-03-02 ✅ Patent 10,300,104 granted on 2019-05-28
US20170056520A1
Human necessities

Multi-arm linker for treating rejection reaction in transplantation

#11 | 2017-03-02 ✅ Patent 10,383,947 granted on 2019-08-20
US20170056518A1
Human necessities

Pharmaceuticals in joint-linker configurations for treating pathological blood clots

#12 | 2016-11-24 ✅ Patent 10,442,861 granted on 2019-10-15
US20160339116A1
Human necessities

Molecular constructs with targeting and effector moieties for treating infectious diseases

#13 | 2016-11-24 ✅ Patent 10,202,455 granted on 2019-02-12
US20160339115A1
Human necessities

Molecular constructs with targeting and effector moieties comprising an SCFV specific for ectodomain of transferrin-1 receptor and fingolimod

#14 | 2016-07-21 ✅ Patent 10,010,626 granted on 2018-07-03
US20160208021A1
Chemistry; metallurgy

Molecular constructs with targeting and effector moieties

#15 | 2016-07-21 ✅ Patent 9,907,858 granted on 2018-03-06
US20160208020A1
Chemistry; metallurgy

Peptide core-based multi-arm linkers

#16 | 2016-07-21 ✅ Patent 10,668,165 granted on 2020-06-02
US20160206754A1
Human necessities

Molecular constructs for treating tumors

Also check out Immunwork Inc.'s (Taipei, Taiwan) applicant profile with 19 patent applications submitted.

AssigneeID:

110837 ⎘